等待開盤 08-14 09:30:00 美东时间
+1.435
+1.99%
Throughout the last three months, 3 analysts have evaluated Solventum (NYSE:SOL...
08-08 20:03
Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $87 to $94.
08-08 19:29
Solventum shares are trading lower. The company reported Q2 financial results.
08-08 04:22
Solventum (NYSE:SOLV) raises FY2025 Adj EPS guidance from $5.45-$5.65 to $5.80-$5.95 vs $5.58 analyst estimate..
08-08 04:14
Companies Reporting Before The Bell • GoHealth (NASDAQ:GOCO) is estimated to re...
08-07 16:33
2025 年已经过半,裁员、削减成本,成为众多药企不得不面对的现实。据 Fierce Biotech 统计,仅在今年 7 月,就有 20 家药企宣布了裁员计划...
08-01 12:49
Reviewing its MedTech coverage ahead of the Q2 earnings season on Tuesday, Morgan Stanley upgraded Steris (NYSE:STE) and Solventum (NYSE:SOLV) to Overweight from Equal Weight and downgraded RxSight (N...
07-16 03:26
Morgan Stanley analyst Patrick Wood upgrades Solventum (NYSE:SOLV) from Equal-Weight to Overweight and raises the price target from $80 to $103.
07-15 21:01
Argus Research analyst John Staszak upgrades Solventum (NYSE:SOLV) from Hold to Buy.
07-01 22:23
The implementation of artificial intelligence systems has expanded the roles of chief technology officers, prompting compensation hikes across an array of sectors from consumer to financial services t...
07-01 21:21